Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.

AI is expanding into medicine. Are the world’s regulators ready?

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

We interview Mary Lavin, President of Sartorius North America, about her career.

Advanz Pharma is fined for substantially hiking the price of a generic drug.

GlaxoSmithKline’s Senior Vice President of US Oncology speaks about the pandemic and its impact on patients.

Why are some COVID-19 vaccines linked to blood clots? Researchers have a theory...

COVID-19 vaccine rollout is a lottery, with some countries faring much better than others.

Is waiving patents for COVID-19 vaccines the right step forward?